Stage IIIB Bladder Cancer AJCC v8

8 clinical trials · Condition

Record	Firm	Date
Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy (NCT04963153)	National Cancer Institute (NCI)	2022-07-07
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma (NCT04940299)	M.D. Anderson Cancer Center	2021-09-23
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies (NCT04902040)	M.D. Anderson Cancer Center	2021-04-14
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913)	City of Hope Medical Center	2019-12-24
Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer (NCT03617913)	Mayo Clinic	2018-09-19
Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy (NCT03319745)	M.D. Anderson Cancer Center	2018-01-11

Every clearance here is in the API, with alerts when new ones post.